Inhibikase Therapeutics, Inc. - Common Stock (NQ: IKT )
2.350
+0.120
(+5.38%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
All News about Inhibikase Therapeutics, Inc. - Common Stock![]()
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 19, 2023
Via Benzinga
![]()
12 Health Care Stocks Moving In Friday's After-Market Session
August 25, 2023
Via Benzinga
![]() ![]() ![]()
Earnings Preview: Inhibikase Therapeutics
May 12, 2023
Via Benzinga
![]() ![]()
Looking Into Inhibikase Therapeutics's Return On Capital Employed
December 27, 2022
Via Benzinga
![]() ![]() Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Benzinga's Top Ratings Upgrades, Downgrades For November 16, 2022
November 16, 2022
Via Benzinga
![]() ![]() ![]() ![]() ![]() ![]()
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|